WO1987004930A1 - Sulphamic science - Google Patents
Sulphamic science Download PDFInfo
- Publication number
- WO1987004930A1 WO1987004930A1 PCT/AU1987/000050 AU8700050W WO8704930A1 WO 1987004930 A1 WO1987004930 A1 WO 1987004930A1 AU 8700050 W AU8700050 W AU 8700050W WO 8704930 A1 WO8704930 A1 WO 8704930A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- treatment
- infection
- solution
- sulphamic
- sloughing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
Definitions
- This treatment may be an alternative to Fluoridation in Dental Health.
- the active ingredient used in all these treatments is H.N.S.O.H. 2 3.
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
An alternative treatment to medication for certain infections. By causing a mild chemical scald of the outer receptive layer of the membrane. The once-off removal of the surface tissue clears off the host material before infection takes place. Desloughing the base removes the medium that pathogens and rinovirus attach to initiate infection. This concept of localised treatment of known points of entry as distinct to general medications. The desloughing agent or active ingredient is H2NSOH3.
Description
SULPHAMIC SCIENCE
1.
1. The advantages of these treatments over orthodox medicines is no ingesting of oral drugs.
2. There is no introduced antigens as in vacines.
3. This treatment may be an alternative to Fluoridation in Dental Health.
4 This programne is a departure from accepted practice but in the limited testing so far has been giving encouraging results.
5. The active ingredient used in all these treatments is H.N.S.O.H. 2 3.
6. The one-off de-sloughing of the target zone or point of entry is a new concept.
7. In the limited tests I have done all have been entirely painless except Claim-No.6.
8. By undertaking the treatment before infection sets in ones body does not have to contend with the illness or the medication. 9 . -WARNING-Some Aut ho r i t i es . F . D . A . o f U . S . A . l i s t
H . N . S ... H . as a hazardous material. 2 3
Claims
CLAIM .1. THE Inventive Idea is in the field of Health Care and Preventive Medicine. To prevent the infection by removing the base or medium where pathogens first get established. By one-off desloughing of the well known point of entry before infection takes place
I have discovered that the chemical Sulphamic Acid. is a strong desloughing agent and has anti-bacterial properties.
DENTAL. HEALTH. By swabbing the gums with awater-based solution of Sulphamic Acid causes a light film to shed off. This film-The host of the organisms of
Streptococus Mutans. Removal of this film leaves adistinct high-water mark across the lower root-end of the teeth and reduces the build-up of plaque coating on the teeth. Length treatment is usually 8-10 days.
The process is totally painless. As this is a new concept I cannot compare it it with usual methods until more study has been undertaken. The active, ingredient in this preparation is
H.N.S.O.H. 2 3
Claim. 2.
The Inventive Idea is in the field of Health Care and Preventive Medicine .
To prevent the infection by removing the base or medium where pathogens first get established.
By one-off de-sloughing of the well known point of entry before infection takes place.
I have discovered that the chemical Sulphamic Acid is a strong desloughing agent and has anti-bacterial properties.
De-sloughing of the troat to reduce infection from Rhino-virus and Common Colds.
A light gargle once per day removes the material the rodent pathogens and Rhino-virus attach to to initiate
Throat infection. THIS treatment is localised to the area where infection begins.
This method does not use any ingested medicines. Length of treatment usually 8-10 days
The process is totally painless. As this is a new concept I cannot compare it with usual methods until more study has been undertaken.
The active ingredient in this preparation is
HNSOH
2 3.
Claim. 3.
The Inventive Idea is in the field of Health Care and Preventive Medicine.
Treatment of Herpes. inboth dormant and active stages.
I have discovered that the chemical Sulphamic Acid is a strong de-sloughant with anti-bacterial properties.
By swabbing an infected area ,or in the Latent form a location that has infected for a period of 8-10 days causes a protective layer to shed-off withno re-ocurrence in the tested time of 2years.
Length of treatment 8-10 days-one application per day with full strength water-based solution.
As this a new concept Icannot compare it with usual methods until more study has been undertaken.
The active ingredient in this preparation is
H.N.S.O.H. 2 3
CLAIM . 4 .
The Inventive Idea is in the field of Health Care, and Preventive Medicine. Pedicare or Relief of Foot Problems. A light application of Sulphamic solution over a period of 20 days or so will remove skin and abnormal growths from the feet including de-sloughing the between surfaces of the toes This removes the base of Tinea infection.
Painlessly removes corns and callouses from the feet to give general foot relief.
Length of treatment 20 days or so apply full strength solution.
The active ingredient in this preparation is.
H.N.S.O.H. 2 3
CLAIM.5.
The Inventive Idea is in the field of Health Care and Preventive Medicine.
Treatment of VARICOSE VEINS.
By swabbing of affected areas with sulphamic solution once every third day will isolate affected veins from circulatory system then shrink and re-absorb them back to almost normal size. It is most important to spread the treatment over several weeks to allow the circulation system to adjust. In the isolation period the treated veins turn black. After a while they shrink in size and return to normal color.
Length of treatment depending on severity up to 60 days.
Solution at full strength is swabbed on once every third day.
The active ingredient in this preparation is
H.N.S.O.H. 2 3
CLAIM. 6. Treatment of resistant facial infections.
I have discovered that Sulphamic solution is a strong de-sloughing agent and anti-bacterial medium . These two qualities combine well to make it a good base to use with other compounds like Salicilic Acid and
Benzoic Acid.
This combination is very effective on the resistant pus-forming infection around the base of the nose.
These infections tend to thicken the skin in the affected area as the pathogens colonise and spread. This solution will de-slough and remove the base of the infection and reduce scar tissue.
IT will inhibit abnormal cell development. Treatment time varies -continue daily application while infection lasts
Stop treatment should de-sloughing become painfull.
The active ingredient in this preparation is.
H.N.S.O.H. 2 3
CLAIM. 7. CONTROL OF DISEASE IN DAIRY CATTLE.
I have discovered Sulphamic solution may be used as a de-sloughing agent to remove skin lesions and Teat callous in the control and prevention of Mastitus, Pseudo-cowpox, Black-spot, and Bovine-Herpes. Used as an additive to normallOdine Teat-dip this solution gradually removes over a period of time the skin lesions that host the Staphycocus Aureus, Streptococus, and other Pathogens. Normally the skin lesions provide protection to the rodent pathogens isolating them from the effect of the Teat- Dipping Treatment.
REmoving this protection de-sloughing greatly increases the benifit of the treament.
The treatment isan ongoing process with a low rate added to regular Teat-dip Mix. 24 grams per Litre.
This strength solution lowers the PH. of the skin surface and improves healing.
The active ingredient in this preparation is
H.N.S.O.H. 2 3
Applications Claiming Priority (10)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU474086 | 1986-02-24 | ||
| AU474186 | 1986-02-24 | ||
| AU473986 | 1986-02-24 | ||
| AU473886 | 1986-02-24 | ||
| AU474286 | 1986-02-24 | ||
| AUPH4742 | 1986-02-24 | ||
| AUPH4740 | 1986-02-24 | ||
| AUPH4738 | 1986-02-24 | ||
| AUPH4739 | 1986-02-24 | ||
| AUPH4741 | 1986-02-24 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| WO1987004930A1 true WO1987004930A1 (en) | 1987-08-27 |
Family
ID=27506529
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/AU1987/000050 Ceased WO1987004930A1 (en) | 1986-02-24 | 1987-02-23 | Sulphamic science |
Country Status (1)
| Country | Link |
|---|---|
| WO (1) | WO1987004930A1 (en) |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE835929C (en) * | 1949-05-12 | 1952-04-07 | August Kettenbach | Means for removing tartar |
| AU534966A (en) * | 1965-07-26 | 1967-11-16 | Wyandotte Chemicals Corporation | Detergent compositions |
| AU1336970A (en) * | 1970-04-03 | 1971-10-07 | ||
| GB2164851A (en) * | 1984-10-01 | 1986-04-03 | Auchincloss Thomas R | Dry, water soluble biocidal compositions |
-
1987
- 1987-02-23 WO PCT/AU1987/000050 patent/WO1987004930A1/en not_active Ceased
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE835929C (en) * | 1949-05-12 | 1952-04-07 | August Kettenbach | Means for removing tartar |
| AU534966A (en) * | 1965-07-26 | 1967-11-16 | Wyandotte Chemicals Corporation | Detergent compositions |
| AU3682768A (en) * | 1967-05-04 | 1969-10-30 | Wyandotte Chemicals Corporation | Iodine disinfectant |
| AU1336970A (en) * | 1970-04-03 | 1971-10-07 | ||
| GB2164851A (en) * | 1984-10-01 | 1986-04-03 | Auchincloss Thomas R | Dry, water soluble biocidal compositions |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA1166575A (en) | Therapeutic dimethyl sulfoxide composition and methods of use | |
| US6264927B1 (en) | Topical solution and method for the treatment of nail fungus | |
| US7198806B2 (en) | Composition and method for treatment and prevention of pruritis | |
| BG64522B1 (en) | Device for the treatment of viral infectiuous diseases | |
| EA018425B1 (en) | Pharmaceutical, disinfectant or preservation extract of trigonella foenum-graecum, method for preparing and use thereof | |
| Iraji et al. | Efficacy of paromomycin ointment in the treatment of cutaneous leishmaniasis: results of a double-blind, randomized trial in Isfahan, Iran | |
| EP1143966B1 (en) | Preparation for warts | |
| JP2005508980A (en) | Stomatitis treatment with patches that promote healing and relieve pain | |
| KR100573206B1 (en) | Use of dichlorobenzyl alcohol and preparations containing dichlorobenzyl alcohol for the preparation of agents for the topical treatment of inflammation | |
| WO1987004930A1 (en) | Sulphamic science | |
| CN110464821A (en) | Draft conserves cream | |
| RU2117473C1 (en) | Method of external treatment of foot and smooth skin mycosis | |
| RU2830816C2 (en) | Use of phospholipid emulsion containing effective amount of dihydroquercetin, lecithin and glycine for treating chronic and inflammatory oral diseases | |
| RU2790528C1 (en) | Method of local treatment of erosive and ulcerative form of flat lichen of the mucous membranes of the mouth | |
| JP2023520867A (en) | Treatment Strategies to Address Post-Injury Facial Contractures | |
| RU2137461C1 (en) | Composition for treatment of mouth cavity sicknesses | |
| Ghosn | Evaluation of sodium stibogluconate in the treatment of cutaneous leishmaniasis in Syria | |
| RU2197950C2 (en) | Agent for mouth cavity rinsing | |
| US12115186B1 (en) | Topical burn cream | |
| RU2082419C1 (en) | Method of treatment of acute respiratory disease | |
| AU2008241370B2 (en) | Essential oil of kunzea ambigua and methods of use | |
| RU2020930C1 (en) | Oxaplast medicinal preparation for removing mycotically affected nails | |
| CN108904638A (en) | A kind of multiduty external application combination drug and application | |
| RU2194495C2 (en) | Method for prophylaxis of tick-induced borreliosis | |
| JPH08509994A (en) | Methods and compositions for topical treatment of damaged tissue using histamine phosphate as the active ingredient |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AK | Designated states |
Kind code of ref document: A1 Designated state(s): DE GB US |
|
| REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |